Spending on Glucagon-Like Peptide-1 Receptor Agonists Among US Adults
This economic evaluation estimates annual total US spending on glucagon-like peptide-1 receptor agonists from 2018 to 2023.
Authors
- Fleetwood Loustalot (ORCID: https://orcid.org/0000-0003-4345-7564)
- Klodiana Myftari
- Gregory Wozniak (ORCID: https://orcid.org/0000-0003-4245-8207)
- Tamkeen Khan (ORCID: https://orcid.org/0000-0002-4522-0811)
- Stavros Tsipas
Institutions
- Centers for Disease Control and Prevention (US)
- American Medical Association (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.2964
- Citations
- 23
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 72.02